Could a laser beam stop chemo mouth sores?

NCT ID NCT01772706

First seen Jul 01, 2026 · Last updated Jul 02, 2026 · Updated 1 time

Summary

This trial investigates whether a low-level diode laser can prevent or reduce severe mouth sores (mucositis) caused by radiation and chemotherapy in people with advanced head and neck cancer. Participants receive either real laser therapy or a non-functional placebo laser during their cancer treatment. The study measures how many patients develop painful mouth sores that affect eating, aiming to find a simple way to ease a common side effect.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
low-level diode laser therapy
What this could lead to
If effective, this laser treatment could become a standard way to prevent painful mouth sores during cancer therapy, improving patients' quality of life.
What could go wrong
This is a mid-stage trial with 97 participants, so results may not apply to all patients. The laser may not reduce severe mucositis more than a placebo.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ORAL MUCOSITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Centre Guillaume le Conquérant

    Le Havre, 76600, France

  • Centre Jean Godinot

    Reims, 51100, France

  • Centre hospitalier universitaire La Milétrie

    Poitiers, 86021, France

  • Clinique Armoricaine de Radiologie

    Saint-Brieuc, 22015, France

  • Hôpital La Pitié Salpêtrière

    Paris, 75013, France

  • Institut de Cancerologie de l'Ouest Paul Papin

    Angers, 49933, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.